What do systematic reviews say?

Lidocaine vs tocainide

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs mexiletine

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs propafenone

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs placebo or no intervention

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs amiodarone

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs dimethylammonium

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs aprindine

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Lidocaine vs pirmenol

The review found no eligible studies for this question.

• Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Tranexamic acid vs placebo

• Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 12 participants
  GRADE not reported

Human activated protein C vs heparin

It is very uncertain whether human activated protein C changes mortality from any cause (15‐day and 30‐day in‐hospital) compared with heparin (very low certainty).

• Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia 2015 · Cochrane Headline outcomes only
  RR 0.51 [0.27, 0.97]
  1 study · 104 participants
  Very low

Dermatan vs heparin

• Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 10 participants
  Very low

Recombinant human soluble thrombomodulin vs heparin

It is very uncertain whether recombinant human soluble thrombomodulin changes mortality from any cause (15‐day and 30‐day in‐hospital) compared with heparin (very low certainty).

• Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia 2015 · Cochrane Headline outcomes only
  RR 0.85 [0.54, 1.36]
  1 study · 227 participants
  Very low

Drain vs No drain

It is very uncertain whether drain changes 30‐day mortality Death during the compared with no drain (very low certainty).

• Abdominal drainage versus no drainage post‐gastrectomy for gastric cancer 2015 · Cochrane Headline outcomes only
  RR 1.73 [0.38, 7.84]
  4 studies · 438 participants
  Very low

Drain vs No drain

• Abdominal drainage versus no drainage post‐gastrectomy for gastric cancer 2015 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 438 participants
  Low

Post‐pyloric tube feeding vs gastric tube feeding

• Post‐pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill… 2015 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 549 participants
  Moderate

Intervention not reported

• The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
  0.99 [0.61, 1.6]
  3 studies · 4758 participants
  Moderate

Intervention not reported

• The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
  0.83 [0.54, 1.29]
  6 studies · 4525 participants
  Low

Intervention not reported

The intervention showed no clear difference in surgical site infection within 30 days in trials with low risk of… (low certainty).

• The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
  RR 0.86 [0.63, 1.17]
  5 studies · 4201 participants
  Low

Intervention not reported

The intervention showed no clear difference in surgical site infection within 30 days, irrespective of risk of bias… (low certainty).

• The effects of high perioperative inspiratory oxygen fraction for adult surgical patients 2015 · Cochrane Headline outcomes only
  RR 0.87 [0.71, 1.07]
  15 studies · 7229 participants
  Low

Standardised formal neonatal resuscitation training (SFNRT) programme vs basic resuscitation training

Standardised formal neonatal resuscitation training (SFNRT) programme showed no clear difference in late neonatal mortality (mortality at > 7 days up to 28 days of life) compared with basic resuscitation training (low certainty).

• Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infants 2015 · Cochrane Headline outcomes only
  RR 0.47 [0.2, 1.11]
  1 study · 3274 participants
  Low